---
figid: PMC5017161__srep33102-f6
figlink: /pmc/articles/PMC5017161/figure/f6/
number: Figure 6
caption: The brief interactions between blood circulation and the liver are depicted.
  The gut microbiota might contribute to the systemic metabolic disorder. PTX administration
  could upregulate the expression of genes and proteins related to fatty acid β-oxidation
  and thereby ameliorate the fatty liver in the mice with combined NAFLD and T2D.
  Furthermore, the glycolysis pathway and BCAA-related pathways could be upregulated
  by PTX. The red and yellow arrows represent significant (P < 0.05) and moderate
  (P > 0.05) changes induced by PTX. The arrow direction indicates PTX-induced upregulation
  or downregulation.
pmcid: PMC5017161
papertitle: Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic
  and dyslipidaemic mice by upregulating fatty acid β-oxidation.
reftext: Jia-Hung Ye, et al. Sci Rep. 2016;6:33102.
pmc_ranked_result_index: '35912'
pathway_score: 0.9539619
filename: srep33102-f6.jpg
figtitle: Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic
  and dyslipidaemic mice by upregulating fatty acid Beta-oxidation
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5017161__srep33102-f6.html
  '@type': Dataset
  description: The brief interactions between blood circulation and the liver are
    depicted. The gut microbiota might contribute to the systemic metabolic disorder.
    PTX administration could upregulate the expression of genes and proteins related
    to fatty acid β-oxidation and thereby ameliorate the fatty liver in the mice with
    combined NAFLD and T2D. Furthermore, the glycolysis pathway and BCAA-related pathways
    could be upregulated by PTX. The red and yellow arrows represent significant (P < 0.05)
    and moderate (P > 0.05) changes induced by PTX. The arrow direction indicates
    PTX-induced upregulation or downregulation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Acetoacetyl-CoA
  - Trimethylamine
  - Acetate
  - Acetoacetate
  - Acetone
  - Alanine
  - Cholesterol
  - Fatty acid
  - Fatty acid B
  - fatty acid
  - Formate
  - Fructose-1,6-BP
  - Fructose-6-P
  - Glucose
  - Glucose-6-P
  - Glutamine
  - Leucine
  - Malonyl-CoA
  - Mevalonate
  - Oxaloacetate
  - Pyruvate
  - Triacylglycerol
  - Valine
  - Lactate
  - 3-hydroxybutyrate
genes: []
chemicals:
- word: Acetoacetyl-CoA
  source: MESH
  identifier: C010667
- word: Trimethylamine
  source: MESH
  identifier: C023336
- word: Acetate
  source: MESH
  identifier: D000085
- word: Acetoacetate
  source: MESH
  identifier: D000090
- word: Acetone
  source: MESH
  identifier: D000096
- word: Alanine
  source: MESH
  identifier: D000409
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: Fatty acid B
  source: MESH
  identifier: D005227
- word: fatty acid
  source: MESH
  identifier: D005227
- word: Formate
  source: MESH
  identifier: D005561
- word: Fructose-1,6-BP
  source: MESH
  identifier: D005632
- word: Fructose-6-P
  source: MESH
  identifier: D005632
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glucose-6-P
  source: MESH
  identifier: D005947
- word: Glutamine
  source: MESH
  identifier: D005973
- word: Leucine
  source: MESH
  identifier: D007930
- word: Malonyl-CoA
  source: MESH
  identifier: D008316
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: Oxaloacetate
  source: MESH
  identifier: D010071
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Triacylglycerol
  source: MESH
  identifier: D014280
- word: Valine
  source: MESH
  identifier: D014633
- word: Lactate
  source: MESH
  identifier: D019344
- word: 3-hydroxybutyrate
  source: MESH
  identifier: D020155
diseases: []
---
